DNDi Template Development Collaboration and License Agreement

• Post author:GHIAA Admin
• Post published:April 14, 2023
• Post category:

Continue ReadingDNDi Template Development Collaboration and License Agreement

MPP – South African Medical Research Council, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement

• Post author:GHIAA Admin
• Post published:March 7, 2023
• Post category:

Continue ReadingMPP – South African Medical Research Council, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement

MPP – Afrigen Biologics, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement

• Post author:GHIAA Admin
• Post published:March 6, 2023
• Post category:

Continue ReadingMPP – Afrigen Biologics, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement

BIND Biosciences, Inc. – Yale University, Cancer Therapeutic, Exclusive License Agreement

• Post author:GHIAA Admin
• Post published:March 3, 2023
• Post category:

Continue ReadingBIND Biosciences, Inc. – Yale University, Cancer Therapeutic, Exclusive License Agreement

CEPI – VBI, COVID-19 Vaccine Development Funding Agreement

• Post author:GHIAA Admin
• Post published:December 12, 2022
• Post category:

Continue ReadingCEPI – VBI, COVID-19 Vaccine Development Funding Agreement

FIND Sample Funding Terms and Conditions

• Post author:GHIAA Admin
• Post published:December 7, 2022
• Post category:

Continue ReadingFIND Sample Funding Terms and Conditions

UnitaidExplore Sample Funding Terms and Conditions

• Post author:GHIAA Admin
• Post published:December 1, 2022
• Post category:

Continue ReadingUnitaidExplore Sample Funding Terms and Conditions

DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement

• Post author:GHIAA Admin
• Post published:October 26, 2022
• Post category:

Continue ReadingDNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement

AXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement

• Post author:GHIAA Admin
• Post published:September 13, 2022
• Post category:

Continue ReadingAXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement